Phosphoric Acid

Phosphoric Acid

SCHEMBL670321

Nc1nc(N)nc(N)n1.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
LMNA P02545 1/20 0.39
CASP1 P29466 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.32
POLB P06746 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL752823 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL10873614 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL300964 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL28199623 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL407305 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL669448 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL73239 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL4801853 1.00 CYP1A2 (0.42) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL23928073 0.97 CYP1A2 (0.40) CYP1A2LMNACASP1SMN1; SMN2POLB
Phosphoric Acid SCHEMBL22345505 0.97 CYP1A2 (0.40) CYP1A2LMNACASP1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3487956-B1 FLAME PROTECTION AGENT MIXTURES, THEIR PREPARATION AND THEIR USE CLARIANT INT LTD (CH) 2026-01-14 EP claimed
EP-3487957-B1 FLAME RETARDANT MIXTURES, THE PRODUCTION AND THE USE THEREOF CLARIANT INT LTD (CH) 2023-04-12 EP claimed
EP-4141059-A1 DIORGANYLPHOSPHINIC SALTS HAVING EXCEPTIONAL SURFACE STRUCTURE Clariant International Ltd (CH) 2023-03-01 EP claimed
US-11312910-B2 Diorganylphosphinic acid salts, method for the production thereof and the use thereof CLARIANT INTERNATIONAL LTD (CH) 2022-04-26 US claimed
EP-3487861-B1 DIORGANYLPHOSPHINIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF CLARIANT INT LTD (CH) 2021-12-01 EP claimed
CN-108779347-B Halogen-free fire-retardant coating capable of forming barrier layer and use thereof 科莱恩塑料和涂料有限公司 2021-09-21 CN claimed
CN-108291050-B Polymeric flame retardant mixtures 科莱恩塑料和涂料有限公司 2021-06-25 CN claimed
US-11028324-B2 Flame retardant mixtures, the production and the use thereof CLARIANT PLASTICS & COATINGS LTD (CH) 2021-06-08 US claimed
EP-3426731-B1 HALOGEN-FREE, INTUMESCENT FIRE-PROOF COATING, AND USE THEREOF CLARIANT INT LTD (CH) 2021-05-12 EP claimed
CN-107637605-B Flame retardant mixtures, their preparation and their use 科莱恩塑料和涂料有限公司 2021-01-05 CN claimed
EP-2145894-B1 Salts of diorganyl phosphinic acids, method for their manufacture and their application CLARIANT PRODUKTE DEUTSCHLAND (DE) 2012-02-29 EP claimed
CN-101906117-A Alkyl phosphinate polymer and preparation method and application thereof JINBIAO YE 2010-12-08 CN claimed
CN-1660857-B Salts of dialkylphosphinic acids CLARIANT GMBH 2010-08-04 CN claimed
EP-1607400-B1 Salts of dialkylphosphinic acids, process for their preparation and their use CLARIANT PRODUKTE DEUTSCHLAND (DE) 2009-12-02 EP claimed
US-7446140-B2 Dialkylphosphinic salts, their use, and a process for their preparation CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2008-11-04 US claimed
US-7420007-B2 Dialkylphosphinic salts CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2008-09-02 US claimed
EP-1544206-B1 Use of salts of dialkylphosphinic acids CLARIANT PRODUKTE DEUTSCHLAND (DE) 2008-03-05 EP claimed
US-20060084734-A1 Dialkylphosphinic salts, their use, and a process for their preparation CLARIANT GMBH 2006-04-20 US claimed
US-20060074157-A1 Including the telomers: ethylbutylphospinic salts, butylbutylphosphinic salts, ethylhexylphosphinic salts, butylhexylphosphinic salts, or hexylhexylphosphinic salts; flame-retardant polymer molding materials CLARIANT GMBH 2006-04-06 US claimed
CN-1660857-A Salts of dialkylphosphinic acids CLARIANT GMBH (DE) 2005-08-31 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312910-B2 Diorganylphosphinic acid salts, method for the production thereof and the use thereof PPIP5K2, DCPS, FDPS CYP1A2 3144/4885LMNA 4078/4885CASP1 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.